BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 8542113)

  • 1. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
    Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
    Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
    Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.
    Günther A; Mosavi P; Heinemann S; Ruppert C; Muth H; Markart P; Grimminger F; Walmrath D; Temmesfeld-Wollbrück B; Seeger W
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):454-62. PubMed ID: 10673185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.
    Gregory TJ; Longmore WJ; Moxley MA; Whitsett JA; Reed CR; Fowler AA; Hudson LD; Maunder RJ; Crim C; Hyers TM
    J Clin Invest; 1991 Dec; 88(6):1976-81. PubMed ID: 1752956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
    Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
    Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
    Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
    Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
    Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
    Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid.
    Schmidt R; Steinhilber W; Ruppert C; Daum C; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2002 Feb; 165(4):470-4. PubMed ID: 11850338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased surfactant protein A in patients with bacterial pneumonia.
    Baughman RP; Sternberg RI; Hull W; Buchsbaum JA; Whitsett J
    Am Rev Respir Dis; 1993 Mar; 147(3):653-7. PubMed ID: 8442601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary surfactant activity is impaired in lung transplant recipients.
    Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
    Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.
    Schmidt R; Markart P; Ruppert C; Wygrecka M; Kuchenbuch T; Walmrath D; Seeger W; Guenther A
    Respir Res; 2007 Jul; 8(1):55. PubMed ID: 17662121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant abnormalities in patients with respiratory failure after multiple trauma.
    Pison U; Seeger W; Buchhorn R; Joka T; Brand M; Obertacke U; Neuhof H; Schmit-Neuerburg KP
    Am Rev Respir Dis; 1989 Oct; 140(4):1033-9. PubMed ID: 2802366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin.
    Bernhard W; Haagsman HP; Tschernig T; Poets CF; Postle AD; van Eijk ME; von der Hardt H
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):41-50. PubMed ID: 9224208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
    Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
    Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
    Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
    Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis.
    Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
    Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
    Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
    Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
    Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
    Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.